UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+5.87%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$4.01B
AUM Growth
+$484M
(+14%)
Cap. Flow
+$336M
Cap. Flow
% of AUM
8.39%
Top 10 Holdings %
Top 10 Hldgs %
56.46%
Holding
586
New
87
Increased
121
Reduced
176
Closed
112
Top Buys
| 1 |
Kellanova
K
|
$305M |
| 2 |
SRCL
Stericycle Inc
SRCL
|
$145M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
$104M |
| 4 |
CHX
ChampionX
CHX
|
$98.2M |
| 5 |
Spirit AeroSystems
SPR
|
$90.4M |
Top Sells
| 1 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
$149M |
| 2 |
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
|
$81.8M |
| 3 |
SWN
Southwestern Energy Company
SWN
|
$56.7M |
| 4 |
Union Pacific
UNP
|
$24.2M |
| 5 |
X
US Steel
X
|
$18.7M |
Sector Composition
| 1 | Energy | 21.14% |
| 2 | Technology | 19.82% |
| 3 | Healthcare | 14.53% |
| 4 | Industrials | 11.25% |
| 5 | Consumer Staples | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Autodesk
ADSK
$69.5B
| $1.38M | 0.03% |
+5,000
| New | +$1.38M |
|
227
Salesforce
CRM
$239B
| $1.37M | 0.03% |
5,000
-15,000
| -75% | -$4.11M |
|
228
Astria Therapeutics
ATXS
$424M
| $1.37M | 0.03% |
124,202
+11,537
| +10% | +$127K |
|
229
IAC Inc
IAC
$2.98B
| $1.35M | 0.03% |
30,475
-3,048
| -9% | -$135K |
|
230
RH
RH
$4.7B
| $1.34M | 0.03% |
+4,000
| New | +$1.34M |
|
231
Larimar Therapeutics
LRMR
$337M
| $1.33M | 0.03% |
202,783
-5,000
| -2% | -$32.8K |
|
232
Orthofix Medical
OFIX
$575M
| $1.33M | 0.03% |
84,883
+7,885
| +10% | +$123K |
|
|
LBPH
233
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $1.31M | 0.03% |
39,260
-12,336
| -24% | -$411K |
|
234
Verastem
VSTM
$663M
| $1.29M | 0.03% |
430,669
+330,280
| +329% | +$988K |
|
|
ITCI
235
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.27M | 0.03% |
17,343
+343
| +2% | +$25.1K |
|
236
Treace Medical Concepts
TMCI
$453M
| $1.26M | 0.03% |
217,755
+4,779
| +2% | +$27.7K |
|
237
Crinetics Pharmaceuticals
CRNX
$3.35B
| $1.26M | 0.03% |
24,693
-428
| -2% | -$21.9K |
|
238
Capricor Therapeutics
CAPR
$308M
| $1.26M | 0.03% |
+82,900
| New | +$1.26M |
|
|
GTY
239
Getty Realty Corp
GTY
$1.63B
| $1.26M | 0.03% |
39,582
-18,846
| -32% | -$599K |
|
240
Prologis
PLD
$105B
| $1.25M | 0.03% |
9,868
-5,411
| -35% | -$683K |
|
241
American Eagle Outfitters
AEO
$3.26B
| $1.23M | 0.03% |
55,000
-55,000
| -50% | -$1.23M |
|
242
InflaRx
IFRX
$112M
| $1.22M | 0.03% |
797,876
+76,108
| +11% | +$116K |
|
243
Alcon
ALC
$39.6B
| $1.2M | 0.03% |
12,009
-245
| -2% | -$24.5K |
|
|
INZY
244
DELISTED
Inozyme Pharma
INZY
| $1.18M | 0.03% |
226,232
+21,014
| +10% | +$110K |
|
245
Ultragenyx Pharmaceutical
RARE
$3.07B
| $1.18M | 0.03% |
21,269
-13,859
| -39% | -$770K |
|
246
Sutro Biopharma
STRO
$89.9M
| $1.17M | 0.03% |
338,222
+63,165
| +23% | +$219K |
|
247
PTC Therapeutics
PTCT
$4.55B
| $1.17M | 0.03% |
31,435
-1,565
| -5% | -$58.1K |
|
248
Analog Devices
ADI
$122B
| $1.15M | 0.03% |
5,000
-2,500
| -33% | -$575K |
|
249
Snowflake
SNOW
$75.3B
| $1.15M | 0.03% |
+10,000
| New | +$1.15M |
|
250
Establishment Labs
ESTA
$1.13B
| $1.14M | 0.03% |
26,358
-2,087
| -7% | -$90.3K |
|